Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03339271 · ClinicalTrials.gov registry record · NA

Technology-enhanced Transitional Palliative Care for Family Caregivers

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
384
Enrollment target

NCT03339271: Completed NA study, sponsored by Mayo Clinic.

NCT03339271 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 384 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03339271, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
384 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effect and cost of technology-enhanced transitional palliative care on family caregivers who provide care to a loved one after a hospitalization.

Primary Outcome

The Preparedness for Caregiving Scale captures how well family caregivers feel they are prepared for the multiple aspects of the caregiving role, using a 4-point response set ranging from 0 ("not at all") to 4 ("very well"). A mean score is calculated; higher scores indicate greater preparation for caregiving.

Interventions

  • BEHAVIORAL Technology-Enhanced Support
  • BEHAVIORAL Usual Care Support

Trial Details

FieldValue
Enrollment Target 384 participants
Start Date 2018-03-20
Est. Completion 2022-07-05
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT03339271 record still lists

NCT03339271 is an interventional study that assigns participants to a tested intervention. The registered 384 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).

The record links to 0 conditions, and to 2 interventions - of which Technology-Enhanced Support is the first listed.

NCT03339271 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03339271 about?

NCT03339271 is a clinical study titled "Technology-enhanced Transitional Palliative Care for Family Caregivers". The purpose of this study is to evaluate the effect and cost of technology-enhanced transitional palliative care on family caregivers who provide care to a loved one after a hospitalization.

What is the current status of trial NCT03339271?

This trial is currently completed. It is a NA study. The enrollment target is 384 participants. The study started on 2018-03-20. Estimated completion is 2022-07-05.

What interventions are being tested in trial NCT03339271?

The interventions under investigation include: Technology-Enhanced Support (BEHAVIORAL), Usual Care Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT03339271?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03339271's enrollment target sits among peer trials

384 271st of 2000 higher than 1,728 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06277661 · 384 participants · NA

    The Mom and Infant Outcomes (MOMI) Study

  • NCT06372964 · 384 participants · Phase 3

    Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

  • NCT06501040 · 384 participants · NA

    Increasing Knowledge and Interest in Cancer Clinical Trials

  • NCT06566703 · 384 participants · NA

    Testing ANSOS for Efficacy in Multi-Tribal Urban Communities

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03339271, the US trial registry maintained by the National Library of Medicine. NCT03339271 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.